TAR-200 plus cetrelimab show encouraging outcomes for MIBC patients ineligible for standard cisplatin-based chemotherapy

EAU 2025: Updates in NMIBC

Enzalutamide with 5-ARI is safe for older patients with castration-sensitive systemic prostate cancer

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Higher visceral fat linked to reduced overall survival in older adults with newly diagnosed gastrointestinal malignancies

Belzutifan is more efficacious than everolimus in the treatment of metastatic renal cell carcinoma

ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib

Time to metastasis after prostatectomy should not be used as a prognostic factor for metachronous mHSPC

Combining chemotherapy with cemiplimab for advanced penile cancer may serve as a viable first-line treatment option

KIM-1 is a good prognostic and predictive biomarker in advanced renal cell carcinoma

Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer

UGN-102 shows better results after 12 months of treatment for low-grade intermediate-risk NMIBC